(Q42619537)

English

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients

scientific article published on 5 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

systemic lupus erythematosus

1 reference

based on heuristic

inferred from title

author name string

Hiroshi Tanaka

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Koji Tsugawa

2

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Eishin Oki

3

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Koichi Suzuki

4

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Etsuro Ito

5

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

publication date

5 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

85-89

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

The validity of the ECLAM index for the retrospective evaluation of disease activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine oral pulse therapy for patients with disease flare of lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of lupus nephritis in children

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term intermittent pulse therapy with mizoribine attenuates histologic progression in young patients with severe lupus nephritis: report of two patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine for the treatment of lupus nephritis in children and adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetic study of mizoribine in renal transplantation patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine: mode of action and effects in clinical use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mizoribine pulse therapy for a pediatric patient with steroid-resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lupus nephritis in children--a review of 167 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment for lupus nephritis: a revisit

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional interaction of the immunosuppressant mizoribine with the 14-3-3 protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/17483980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-007-0635-9

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42619537&oldid=1967465805"